Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Harvard Business School
US Army
Novartis
Farmers Insurance
US Department of Justice
Mallinckrodt
Covington
Citi
Colorcon

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,060,085

« Back to Dashboard

Which drugs does patent 6,060,085 protect, and when does it expire?

Patent 6,060,085 protects ACZONE and is included in two NDAs.

This patent has thirty-five patent family members in twenty-two countries.
Summary for Patent: 6,060,085
Title: Compositions and methods for topical application of therapeutic agents
Abstract:The present invention generally relates to pharmaceutical compositions that enable control of drug delivery properties and the development of optimal drug delivery strategies customized for particular drugs and particular diseases. The composition includes a dissolved pharmaceutical that has the capacity to permeate the stratum corneum layer of the epidermis and become available systemically, and a pharmaceutical in a microparticulate state that does not readily cross the stratum corneum of the epidermis. The dissolved and microparticulate pharmaceuticals may be the same or different pharmaceuticals. Methods for the preparation and use of the compositions are also provided. In a preferred embodiment, the invention finds particular use in a formulation for the topical application of dapsone for the treatment of acne. In another preferred embodiment, the invention finds particular use for the treatment of herpes lesions.
Inventor(s): Osborne; David W. (The Woodlands, TX)
Assignee:
Application Number:09/201,521
Patent Claim Types:
see list of patent claims
Use; Composition; Delivery; Process; Formulation;

Drugs Protected by US Patent 6,060,085

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Allergan ACZONE dapsone GEL;TOPICAL 021794-001 Jul 7, 2005 AB RX Yes Yes ➤ Subscribe ➤ Subscribe TREATMENT OF ACNE ➤ Subscribe
Allergan Inc ACZONE dapsone GEL;TOPICAL 207154-001 Feb 24, 2016 RX Yes Yes ➤ Subscribe ➤ Subscribe TREATMENT OF ACNE ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 6,060,085

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,863,560 Compositions and methods for topical application of therapeutic agents ➤ Subscribe
6,620,435 Compositions for topical application of therapeutic agents ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,060,085

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Slovenia 1485059 ➤ Subscribe
Portugal 1485059 ➤ Subscribe
Portugal 957900 ➤ Subscribe
New Zealand 535363 ➤ Subscribe
Norway 20043877 ➤ Subscribe
Mexico PA02006593 ➤ Subscribe
South Korea 100864129 ➤ Subscribe
South Korea 20040085214 ➤ Subscribe
Japan 2006096774 ➤ Subscribe
Japan 2005524651 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Moodys
Citi
Novartis
QuintilesIMS
Cantor Fitzgerald
McKinsey
US Department of Justice
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot